Mechanical Interference Versus Neural Mobilization on Ulnar Neuropathy Post Cubital Tunnel Syndrome
Launched by CAIRO UNIVERSITY · Jul 1, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different treatment methods for people with ulnar neuropathy, a condition that can occur after surgery for cubital tunnel syndrome, which affects the elbow area. The study will compare "mechanical interference" and "neural mobilization" to see which method is more effective in helping patients recover and relieve their symptoms.
To be eligible for this trial, participants should be between the ages of 20 and 55 and have been diagnosed with cubital tunnel syndrome by an orthopedic doctor. They should also have a recent test confirming issues with their ulnar nerve. However, individuals with certain conditions, like diabetes or previous surgeries on their hand or elbow, cannot participate. If you join the study, you can expect to receive one of the two treatment methods and be monitored for its effects on your condition. This trial aims to provide more information on how to best treat ulnar neuropathy after surgery and improve recovery for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patients were diagnosed and referred by an orthopedist.
- • The patient's age ranged from 20 to 55 years old.
- • Recent NCV for ulnar nerve confirming the diagnosis.
- • Unilateral cubital tunnel syndrome with ulnar neuropathy
- Exclusion Criteria:
- • Patients with cervical brachialgia.
- • Patients with metabolic diseases such as diabetes, severe thyroid disorders, anemia, and -pregnancy.
- • Hypertensive patients or patients who had a previous hand or elbow surgery.
- • Patients with median nerve involvement in proximal areas such as thoracic outlet syndrome.
- • History of carpal tunnel release surgery. Steroid injection
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported